Login / Signup
Cecilia A Frecha
(Cecilia Frecha)
ResearcherID
ORCID
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 4
Top Topics
Replacement Therapy
Drug Induced
Radical Prostatectomy
Inflammatory Response
Top Venues
Allergy
The oncologist
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Céspedes José Antonio
,
Rubén Fernández Santamaria
,
Gador Bogas
,
Adriana Ariza Veguillas
,
Immaculada Doña
,
Maria Salas
,
Marina Labella
,
Tahia Diana Fernandez
,
Cristobalina Mayorga
,
Torres María José
,
Cecilia A Frecha
Lipopolysaccharides in combination with amoxicillin increases basophil activation test sensitivity to amoxicillin IgE-mediated hypersensitivity.
Allergy
79 (9) (2024)
Céspedes José Antonio
,
Rubén Fernández Santamaria
,
Gador Bogas
,
Adriana Ariza Veguillas
,
Immaculada Doña
,
Maria Salas
,
Marina Labella
,
Tahia Diana Fernandez
,
Cristobalina Mayorga
,
Torres María José
,
Cecilia A Frecha
Lipopolysaccharides in combination with amoxicillin increases basophil activation test sensitivity to amoxicillin IgE-mediated hypersensitivity.
Allergy
79 (9) (2024)
Céspedes José Antonio
,
Rubén Fernández Santamaria
,
Gador Bogas
,
Adriana Ariza Veguillas
,
Immaculada Doña
,
Maria Salas
,
Marina Labella
,
Tahia Diana Fernandez
,
Cristobalina Mayorga
,
Torres María José
,
Cecilia A Frecha
LPS in combination with amoxicillin increases BAT sensitivity to amoxicillin IgE-mediated hypersensitivity.
Allergy
(2024)
Rafael Adrián Pacheco-Orozco
,
Lorena Montealegre-Páez
,
Federico Cayol
,
Héctor Martínez-Gregorio
,
Javier Oliver
,
Cecilia A Frecha
,
Felipe Vaca Paniagua
,
Sandra Perdomo
AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis.
The oncologist
25 (12) (2020)